PT - JOURNAL ARTICLE AU - Luis M. García-Marín AU - Adrián I. Campos AU - Pik-Fang Kho AU - Nicholas G. Martin AU - Gabriel Cuéllar-Partida AU - Miguel E. Rentería TI - <em>Big data</em> screening identifies 110 complex traits causally associated with obesity AID - 10.1101/2020.10.20.20216598 DP - 2020 Jan 01 TA - medRxiv PG - 2020.10.20.20216598 4099 - http://medrxiv.org/content/early/2020/10/23/2020.10.20.20216598.short 4100 - http://medrxiv.org/content/early/2020/10/23/2020.10.20.20216598.full AB - Background/Objectives Obesity has become a serious public health concern worldwide due to the rapid increase in its prevalence and its multiple negative health consequences. Here we sought to identify causal relationships between obesity and other complex traits and conditions using a data-driven hypothesis-free approach that relies on genetic data to infer causal associations.Subjects/Methods We leveraged available summary-based genetic data from genome-wide association studies on 1 498 phenotypes and applied the latent causal variable method (LCV) between obesity and all traits.Results We identified 110 traits with significant causal associations with obesity. Results show obesity influencing 26 phenotypes associated with cardiovascular diseases, 22 anthropometric measurements, 9 with the musculoskeletal system, 9 with behavioural or lifestyle factors including loneliness or isolation, 6 with respiratory diseases, 5 with body bioelectric impedances, 4 with psychiatric phenotypes, 4 with the nervous system, 4 with disabilities or long-standing illness, 3 with the gastrointestinal system, 3 with use of analgesics, 2 with metabolic diseases such as diabetes, 1 with inflammatory response and 1 with the neurodevelopmental disorder ADHD, among others.Conclusions Our results indicate that obesity is primarily the cause, not the consequence of other underlying traits or comorbid diseases. The wide array of causally associated phenotypes provides an overview of the metabolic, physiological, and neuropsychiatric impact of obesity.Competing Interest StatementGC-P contributed to this study while employed at The University of Queensland. He is now an employee of 23andMe Inc. and he may hold stock or stock options. All other authors declare having no conflicts of interest.Funding StatementA.I.C. is supported by a UQ Research Training Scholarship from The University of Queensland (UQ). M.E.R. thanks support of the NHMRC and Australian Research Council (ARC) through a Research Fellowship (GNT1102821). P.F.K. is supported by an Australian Government Research Training Program Scholarship from Queensland University of Technology (QUT).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the Human Research Ethics Committee of the QIMR Berghofer Medical Research Institute.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData can be obtained from the authors upon reasonable request. The results can be perused on CTG-VIEW. https://view.genoma.io/gwas/5d81f54cbd15223346bab2cd